| Product Name | MF | CAS | Details |
|---|
| TAS05567 | C21H29N9O2 | 1429038-15-2 | Details |
| VU041 | C19H20F3N3O | 332943-64-3 | Details |
| MR 16728 hydrochloride | C23H37ClN2O | 207403-36-9 | Details |
| 3M-011 | C18H25N5O3S | 642473-62-9 | Details |
| CDK8-IN-3 | C22H23N5O2 | 1884500-15-5 | Details |
| MK-8318 | C27H26F4N2O5 | 1416581-40-2 | Details |
| 5-Et-ddU | C11H16N2O4 | 108895-49-4 | Details |
| Notch inhibitor 1 | C26H25F7N4O3 | 1584647-27-7 | Details |
| AZD0424 | C25H29ClN6O5 | 692054-06-1 | Details |
| Amitifadine free base | C11H11Cl2N | 410074-73-6 | Details |
| Crizotinib acetate | C23H26Cl2FN5O3 | 877399-53-6 | Details |
| Azt-pmap | C20H25N6O8P | 142629-81-0 | Details |
| SDM25N hydrochloride | C26H27ClN2O3 | 342884-71-3 | Details |
| Levofloxacin sodium | C18H21FN3NaO4 | 872606-49-0 | Details |
| BMT-090605 | C21H24N4O2 | 1551403-51-0 | Details |
| ML-9 Free Base | C15H17ClN2O2S | 110448-31-2 | Details |
| Hypoglycemic agent 1 | C25H24FN5O4 | 2253733-57-0 | Details |
| Afurolol | C15H21NO4 | 65776-67-2 | Details |
| Rhodamine 123 free base | C21H17N2O3+ | 104114-27-4 | Details |
| (S)-BI-1001 | C19H15BrClNO3 | 957889-73-5 | Details |
| WAY 629 hydrochloride | C15H19ClN2 | 57756-44-2 | Details |
| PSB-1114 tetrasodium | C10H16F2N2NaO13P3S | 1657025-60-9 | Details |
| Seletracetam | C10H14F2N2O2 | 357336-74-4 | Details |
| Vandetanib Fumarate | C22H24BrFN4O2 | 338992-00-0 | Details |
| Irbesartan HCl | C25H29ClN6O | 329055-23-4 | Details |
| SB-267268 | C22H24F3N3O4 | 205678-26-8 | Details |
| MRS2500 tetraammonium | C13H21IN6O8P2 | 630103-23-0 | Details |
| JNJ-46281222 | C23H25F3N4 | 1254980-38-5 | Details |
| Mesulergine hydrochloride | C18H27ClN4O2S | 72786-12-0 | Details |
| BI-1950 | C32H26Cl2FN7O3 | 1159724-42-1 | Details |
| PS315 | C23H19ClO2 | 1221964-50-6 | Details |
| Hsp90-Cdc37-IN-1 | C43H57FN2O6S | 2227303-22-0 | Details |
| Mcl1-IN-3 | C27H22ClN3O4 | 1814891-79-6 | Details |
| BMS-248360 | C36H45N5O5S | 254737-87-6 | Details |
| TA-316 | C28H25BrN4O5S2 | 1429321-13-0 | Details |
| PSB 11 hydrochloride | C16H18ClN5O | 453591-58-7 | Details |
| GNE-0946 | C22H12ClF3N2O4 | 1677667-24-1 | Details |
| LY88074 analog 1 | C25H21NO5S | 183060-99-3 | Details |
| BRD9185 | C23H21F6N3O2 | 2057420-29-6 | Details |
| PKF050-638 | C13H13ClN4O2 | 528893-52-9 | Details |
| Retosiban | C27H34N4O5 | 820957-38-8 | Details |
| RX 67668 | C16H24ClN | 40709-76-0 | Details |
| Codon readthrough inducer 1 | C15H11N3O5 | 1338233-09-2 | Details |
| Autotaxin-IN-1 | C21H23N7O2 | 1619971-30-0 | Details |
| Taribavirin | C8H13N5O4 | 119567-79-2 | Details |
| PCS1055 dihydrochloride | C27H33ClN4 | 361979-40-0 | Details |
| Aganodine | C9H10Cl2N4 | 86696-87-9 | Details |
| TRPA1 Antagonist 1 | C24H23F6N5NaO7PS | 1984825-08-2 | Details |
| FN-1501-propionic acid | C25H27N9O4 | 2408642-48-6 | Details |
| AP5 | C28H28FNO4 | 1623194-37-5 | Details |
| TP-008 | C20H15ClFN5O2 | 1976038-41-1 | Details |
| Diarylalkane derivative 1 | C34H51NO4 | 191155-65-4 | Details |
| XL-784 free base | C21H22ClF2N3O8S | 1356992-21-6 | Details |
| TGFBR1-IN-1 | C23H17N5O2S | 2170830-26-7 | Details |
| TSHR antagonist S37a | C25H20N2O3S2 | 2143452-20-2 | Details |
| Telomerase-IN-3 | C19H16ClN5O3 | 150096-77-8 | Details |
| TD-0212 TFA | C30H35F4N3O6S | 1073549-11-7 | Details |
| TL02-59 dihydrochloride | C32H35ClF3N5O4 | 2415263-06-6 | Details |
| USP7-IN-6 | C41H43N7O4S | 2166586-47-4 | Details |
| AN7973 | C19H17BClN3O3 | 1620899-32-2 | Details |
| SSTR5 antagonist 1 | C28H34FN3O5 | 1628741-91-2 | Details |
| SMYD2-IN-1 | C25H25Cl2F2N7O2 | 2023788-96-5 | Details |
| Syncytial Virus Inhibitor-1 | C23H26N4O3S | 1422496-79-4 | Details |
| UbcH5c-IN-1 | C22H21BrO3 | 2123480-72-6 | Details |
| Sitravatinib malate | C37H35F2N5O9S | 2244864-88-6 | Details |
| TAB29 | C28H22O3 | 2361144-71-8 | Details |
| VU6005806 | C17H16F3N7O2S | 2180914-37-6 | Details |
| CCG258208 | C24H25FN4O4 | 2055990-90-2 | Details |
| TDP1 Inhibitor-1 | C26H26N2O5 | 2248702-80-7 | Details |
| SRT3657 | C40H54N8O6S | 1383551-17-4 | Details |
| TAK-828F | C28H32FN3O5 | 1854901-94-2 | Details |
| β-glycosidase-IN-1 | C13H23NO5 | 176485-27-1 | Details |
| Top1 inhibitor 1 | C24H22N6O2 | 2302772-05-8 | Details |
| Cys modifier 1 | C18H15N5O5 | 2374314-08-4 | Details |
| LP-922761 | C21H26N6O3 | 1454808-95-7 | Details |
| O-2050 | C23H31NO4S | 1883545-42-3 | Details |
| Neurodegenerative Disorder-Targeting Compound 1 | C28H28N4O4 | 1254698-39-9 | Details |
| MAK683-CH2CH2COOH | C23H21FN6O3 | 2639882-68-9 | Details |
| Synucleozid hydrochloride | C22H21ClN6 | 2741856-68-6 | Details |
| Daporinad hydrochloride | C24H30ClN3O2 | 1785666-54-7 | Details |
| ZEN-3411 | C21H20N4O2 | 1952264-36-6 | Details |
| Leuphasyl TFA | C31H40F3N5O9 | 67586-27-0 | Details |
| Wnt pathway activator 2 | C17H15NO4 | 1360540-82-4 | Details |
| ZEN-3219 | C19H18N2O3 | 1952264-34-4 | Details |
| Xanthine amine congener trihydrochloride | C21H29ClN6O4 | 2459963-12-1 | Details |
| Gemcitabine elaidate hydrochloride | C27H43F2N3O5.ClH | 2918768-08-6 | Details |
| ZEN-3862 | C19H17FN2O3 | 1952264-33-3 | Details |
| TXNIP-IN-1 | C12H12N2O4 | 1268955-50-5 | Details |
| AMG-1694 | C23H30F3N3O4S2 | 1361217-07-3 | Details |
| MK-0674 | C26H27F6N3O2 | 887781-62-6 | Details |
| (S)-PF-03716556 | C22H26N4O3 | 928774-44-1 | Details |
| Zindoxifene | C21H21NO4 | 86111-26-4 | Details |
| Ascamycin | 91432-48-3 | Details |
| VHL Ligand 8 | C23H29N3O6 | 2701565-76-4 | Details |
| Asenapine hydrochloride | C17H17Cl2NO | 1261398-77-9 | Details |
| 5-TAMRA chloride(91809-66-4 free base) | C25H23ClN2O5 | 125481-77-8 | Details |
| (S)-Purvalanol B | C20H25ClN6O3 | 2310135-61-4 | Details |
| MK-0493 | C30H38ClF2N3O2 | 455956-93-1 | Details |
| 8-CSC | C16H15ClN4O2 | 148589-13-3 | Details |
| CI 972 anhydrous | C11H12ClN5OS | 115787-68-3 | Details |
| Product Total： Product Page： | ||||
| 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||